Redaelli Veronica, Ricci Martina, Del Sole Angelo, Piccione Marina, Prioni Sara, Rossi Giacomina
Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Neurology V and Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
J Alzheimers Dis Rep. 2025 Apr 2;9:25424823241296017. doi: 10.1177/25424823241296017. eCollection 2025 Jan-Dec.
Familial cases of Alzheimer's disease (AD) with autosomal dominant transmission and early onset have a prevalence around 1%. Since only a small fraction of them has a monogenic inheritance due to , and genes, genetic studies are ongoing to unravel the missing heritability. By sequencing panels including multiple dementia-related genes, we identified a novel likely pathogenic mutation in in a pedigree including five members affected by AD. This loss of function mutation may lead to a reduction of SORL1 receptor, worsening amyloidogenic burden. As the contribution of mutations to heritability of AD is presently not well established, we think that it is very important to signal new familial (likely) pathogenic mutations in order to define the actual genetic involvement of in AD pathogenesis.
常染色体显性遗传且早发的家族性阿尔茨海默病(AD)患病率约为1%。由于其中只有一小部分因 、 和 基因具有单基因遗传,因此正在进行基因研究以揭示缺失的遗传力。通过对包括多个与痴呆相关基因的测序面板,我们在一个有五名成员患AD的家系中鉴定出 基因的一个新的可能致病突变。这种功能丧失突变可能导致SORL1受体减少,加重淀粉样蛋白生成负担。由于 突变对AD遗传力的贡献目前尚未明确,我们认为指出新的家族性(可能)致病 突变对于确定 基因在AD发病机制中的实际遗传作用非常重要。